InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-7.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Demopulos Gregory A MD, Chairman & CEO. Insider active across 2 companies, notably OMEROS CORP. In total, 7 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €23k. Activity tracked since 19 May 2021. The latest transaction was disclosed on 17 November 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
15,000 shares@ US$1.685.3% of flowCommon StockSEC:0001437749-23-032809:0
Ideal exit: 13 Aug 2024 (T+270)
37,500 shares@ US$1.2910.2% of flowCommon StockSEC:0001437749-23-032239:0
36,856 shares@ US$4.100.014% mcap33.4% of flowCommon StockSEC:0001415889-21-003077:0
36,856 shares@ US$4.1028.2% of flowCommon StockSEC:0001415889-21-003077
36,857 shares@ US$4.10100.0% of flowCommon StockSEC:0001415889-21-002642
36,857 shares@ US$4.100.014% mcap33.3% of flowCommon StockSEC:0001415889-21-002642:0
100,000 sharesCommon StockSEC:0000899243-16-011745:0
7 of 7 declarations
About Demopulos Gregory A MD
Demopulos Gregory A MD is Chairman, CEO, and President at OMEROS CORP. He is responsible for the strategic direction of the company, which specializes in developing treatments for rare diseases. His leadership is essential in guiding growth and innovation within OMEROS.
